Overview
TCM is a New Jersey-based investment management firm organized on June 15, 2016 as a
Delaware limited liability company. The Firm is 100% owned by Jay Genzer, who serves as
portfolio manager and is responsible for all investment-related decisions. TCM invests client
assets primarily in publicly-traded global equities, both long and short, across all industries and
market capitalization ranges. TCM and its affiliates provide investment advisory services and
certain administrative services to the following pooled investment vehicle clients on a
discretionary basis (each a “Fund” or “Client and, collectively, the “Funds” or “Clients”):
1. Thames Absolute Return Master Fund, Ltd. (the “Master Fund”);
2. Thames Absolute Return Fund, LP (the “Domestic Feeder Fund”); and
3. Thames Absolute Return Offshore Fund, Ltd. (the “Offshore Feeder Fund”, and
collectively with the Domestic Feeder Fund, the “Feeder Funds”).
The Feeder Funds invest substantially all of their assets in the Master Fund.
Thames Capital GP, LLC (the “General Partner”), a Delaware Limited Liability Company, serves
as the general partner of the Master Fund and the Domestic Feeder Fund. Messrs. Jay Genzer,
Padraig Hoare, and Scott Dakers serve as Directors (the “Directors”) of the Offshore Feeder Fund.
Unless and only to the extent that the context otherwise requires, all references to TCM include
the General Partner and the Directors.
TCM’s investment objective is to generate long-term capital appreciation based
on security
selection and portfolio construction. TCM seeks to achieve these investment objectives primarily
by investing in long and short positions in global equity securities across all industries and market
capitalization ranges, and may utilize options and futures instruments. TCM’s investment strategy
includes both “growth and “value” oriented investments, and TCM may also, from time to time,
invest in “special situation” issuers.
In providing services to the Funds, TCM (i) manages the Funds’ assets in accordance with the
terms of the applicable Fund’s Confidential Private Offering Memorandum or Confidential
Explanatory Memorandum and individual limited partnership agreements (the “Offering
Documents”); (ii) formulates investment objectives; (iii) directs and manages the investment and
reinvestment of the Funds’ assets; and (iv) provides periodic reports to Limited Partners.
Investment restrictions for the Funds, if any, are generally established in the applicable Fund’s
Offering Documents.
TCM does not currently offer investment advisory services to separately managed accounts or
other services tailored to the needs of individual Limited Partners, although TCM may provide
such investment advisory services in the future. TCM does not participate in wrap free programs.
As of December 31, 2023, TCM’s regulatory assets under management were approximately
$231,442,255, all of which are managed on a discretionary basis. TCM does not manage assets on a
non-discretionary basis.